vs
Side-by-side financial comparison of MEDALLION FINANCIAL CORP (MFIN) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
MEDALLION FINANCIAL CORP is the larger business by last-quarter revenue ($70.6M vs $57.6M, roughly 1.2× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 25.4%).
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
MFIN vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.6M | $57.6M |
| Net Profit | $12.2M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | 29.3% | — |
| Net Margin | 17.3% | — |
| Revenue YoY | 25.4% | 94.1% |
| Net Profit YoY | 20.3% | 71.6% |
| EPS (diluted) | $0.50 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.6M | $57.6M | ||
| Q3 25 | $58.7M | $49.5M | ||
| Q2 25 | $62.6M | $39.5M | ||
| Q1 25 | $63.0M | $28.5M | ||
| Q4 24 | $56.3M | $29.7M | ||
| Q3 24 | $53.3M | $16.4M | ||
| Q2 24 | $51.0M | $7.3M | ||
| Q1 24 | $53.3M | — |
| Q4 25 | $12.2M | — | ||
| Q3 25 | $7.8M | $-30.0M | ||
| Q2 25 | $11.1M | $-75.8M | ||
| Q1 25 | $12.0M | $-94.3M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $8.6M | $-85.6M | ||
| Q2 24 | $7.1M | $-91.4M | ||
| Q1 24 | $10.0M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | 29.3% | — | ||
| Q3 25 | 33.2% | -30.8% | ||
| Q2 25 | 31.1% | -151.7% | ||
| Q1 25 | 32.1% | -276.5% | ||
| Q4 24 | 32.8% | — | ||
| Q3 24 | 26.6% | -433.0% | ||
| Q2 24 | 24.3% | -1055.4% | ||
| Q1 24 | 33.6% | — |
| Q4 25 | 17.3% | — | ||
| Q3 25 | 13.2% | -60.5% | ||
| Q2 25 | 17.7% | -191.9% | ||
| Q1 25 | 19.1% | -330.7% | ||
| Q4 24 | 18.0% | — | ||
| Q3 24 | 16.1% | -523.3% | ||
| Q2 24 | 13.9% | -1248.6% | ||
| Q1 24 | 18.8% | — |
| Q4 25 | $0.50 | — | ||
| Q3 25 | $0.32 | $-0.41 | ||
| Q2 25 | $0.46 | $-1.05 | ||
| Q1 25 | $0.50 | $-1.31 | ||
| Q4 24 | $0.43 | — | ||
| Q3 24 | $0.37 | $-1.32 | ||
| Q2 24 | $0.30 | $-1.56 | ||
| Q1 24 | $0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.3M | $130.0M |
| Total DebtLower is stronger | $216.0M | $209.1M |
| Stockholders' EquityBook value | $408.6M | $-438.2M |
| Total Assets | $3.0B | $259.1M |
| Debt / EquityLower = less leverage | 0.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.3M | $130.0M | ||
| Q3 25 | $72.5M | $135.2M | ||
| Q2 25 | $110.4M | $149.6M | ||
| Q1 25 | $131.5M | $212.3M | ||
| Q4 24 | $98.2M | $297.3M | ||
| Q3 24 | $120.6M | $334.7M | ||
| Q2 24 | $87.7M | $276.2M | ||
| Q1 24 | $54.8M | — |
| Q4 25 | $216.0M | $209.1M | ||
| Q3 25 | $215.7M | $207.1M | ||
| Q2 25 | $199.9M | $205.1M | ||
| Q1 25 | $199.7M | $203.2M | ||
| Q4 24 | $232.2M | $201.4M | ||
| Q3 24 | $232.0M | $175.7M | ||
| Q2 24 | $230.8M | $174.4M | ||
| Q1 24 | $225.6M | — |
| Q4 25 | $408.6M | $-438.2M | ||
| Q3 25 | $397.4M | $-422.5M | ||
| Q2 25 | $389.9M | $-405.8M | ||
| Q1 25 | $380.2M | $-338.4M | ||
| Q4 24 | $370.2M | $-253.6M | ||
| Q3 24 | $362.4M | $-187.1M | ||
| Q2 24 | $354.0M | $-233.8M | ||
| Q1 24 | $349.0M | — |
| Q4 25 | $3.0B | $259.1M | ||
| Q3 25 | $2.9B | $240.3M | ||
| Q2 25 | $2.9B | $250.2M | ||
| Q1 25 | $2.8B | $294.2M | ||
| Q4 24 | $2.9B | $378.3M | ||
| Q3 24 | $2.9B | $387.0M | ||
| Q2 24 | $2.8B | $319.4M | ||
| Q1 24 | $2.6B | — |
| Q4 25 | 0.53× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.51× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.63× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.65× | — | ||
| Q1 24 | 0.65× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $-166.8M |
| Free Cash FlowOCF − Capex | — | $-167.0M |
| FCF MarginFCF / Revenue | — | -290.0% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | 10.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $-166.8M | ||
| Q3 25 | $67.0M | $-14.1M | ||
| Q2 25 | $-10.7M | $-62.7M | ||
| Q1 25 | $36.3M | $-84.9M | ||
| Q4 24 | $108.7M | $-266.8M | ||
| Q3 24 | $24.6M | $-63.6M | ||
| Q2 24 | $27.6M | $-70.7M | ||
| Q1 24 | $32.3M | — |
| Q4 25 | — | $-167.0M | ||
| Q3 25 | — | $-14.1M | ||
| Q2 25 | — | $-62.8M | ||
| Q1 25 | — | $-84.9M | ||
| Q4 24 | — | $-266.9M | ||
| Q3 24 | — | $-63.6M | ||
| Q2 24 | — | $-70.8M | ||
| Q1 24 | — | — |
| Q4 25 | — | -290.0% | ||
| Q3 25 | — | -28.6% | ||
| Q2 25 | — | -159.0% | ||
| Q1 25 | — | -297.9% | ||
| Q4 24 | — | -899.8% | ||
| Q3 24 | — | -389.0% | ||
| Q2 24 | — | -966.2% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | — |
| Q4 25 | 10.35× | — | ||
| Q3 25 | 8.63× | — | ||
| Q2 25 | -0.97× | — | ||
| Q1 25 | 3.02× | — | ||
| Q4 24 | 10.72× | — | ||
| Q3 24 | 2.86× | — | ||
| Q2 24 | 3.89× | — | ||
| Q1 24 | 3.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
